The antithrombotic drugs market size is poised to grow by $23M from 2022 to 2027, according to a report by Technavio. The market's growth momentum will progress at a CAGR of 8.42%.
An increase in coagulation disorders drives the growth of the antithrombotic drugs market. Since people are leading unhealthy lifestyles that lack physical activities, there is a greater prevalence of cardiovascular disorders, kidney disorders, and strokes.
Furthermore, deep vein thrombosis and pulmonary embolism are two of the most common blood disorders globally. Such a condition is treated using antithrombotics. Hence, such factors drive the growth of the antithrombotic drugs market during the forecast period.
The oral segment will be significant during the forecast period. The growth of the segment can be attributed to the growing popularity of prescription-based drugs, such as oral capsules. INorth America will contribute 41% to the growth of the global market during the forecast period. The US and Canada are the leading revenue-generating countries in the regional market. The regional market growth can be attributed to factors such as the increasing awareness of the severity of diseases such as DVT and pulmonary embolism and the advanced healthcare system in the US.